Audio is streamed from the publisher.
Chapters
Read from the show notes
- 0:00 The bro-science problem
- 1:51 Meet Tanna Donalson, PA-C
- 3:04 What a peptide actually is
- 4:03 Why your GLP-1 is its own category
- 7:35 The legal gray area explained
- 9:26 The funding gap: why no one studies them
- 14:36 What the FDA meeting is really about
- 19:39 The seven peptides, one by one
- 29:34 Six FDA safety concerns and cancer risk
- 32:44 Two questions for a legit provider
Not from the publisher — times may be approximate.
Show notes
Send us Fan Mail That "miracle" peptide in an unlabeled vial isn't the same science as your GLP-1, and the FDA is meeting this week to decide the fate of seven of them. Registered dietitian and GLP-1 user Ana Reisdorf sits down with Tanna Donalson, PA-C, owner of Redbud Medical in Denver, where she prescribes, manages, and monitors peptides for her patients every day. After 15 years in trauma and emergency medicine, Tanna built a practice around exactly this: knowing what each peptide is, what it actually does for a patient, and how to run it safely. Together they break down why semaglutide (Ozempic) and tirzepatide (Zepbound, Mounjaro) belong in a category all their own, the seven peptides on the FDA's table, and the two questions that reveal whether a peptide provider is legit. IN THIS EPISODE - What a peptide actually is, and why your GLP-1 is NOT the same thing as BPC-157 or TB-500 - The seven peptides the FDA is reviewing: BPC-157, KPV, TB-500 (the "Wolverine complex"), MOTS-c, DSIP, Semax, and Epitalon - The "funding gap" — why peptides that can't be patented never get human clinical trials - Six things the FDA worries about in an unlabeled vial, from identity and purity to the cancer/angiogenesis risk - The two questions that tell you if a peptide provider is legitimate (503A/B pharmacies and third-party certificates of analysis) ABOUT THE GUEST Tanna Donalson is a Physician Assistant and Owner of Redbud Medical in Denver Colorado. Her background is in Trauma and Emergency Medicine and she is now specializing in Women's Health and Wellness, Peptides, Weight Loss, Hormones and all things preventative care to help people live longer, healthier lives. CONNECT WITH TANNA Website: https://www.redbudmedicalspa.com Instagram: @redbudmedspa SPONSORS Timeline Mitopure — Urolithin A gummies that support mitochondrial renewal and muscle health during midlife and GLP-1 use. http://timeline.com/glp1hub for 20% off Cozy Earth — Temperature-regulating viscose bamboo sheets, blankets, and loungewear for better sleep on your GLP-1 journey. http://cozyearth.com code GLP1Hub for up to 20% off CHAPTERS 00:00 The bro-science problem 01:51 Meet Tanna Donalson, PA-C 03:04 What a peptide actually is 04:03 Why your GLP-1 is its own category 07:35 The legal gray area explained 09:26 The funding gap: why no one studies them 14:36 What the FDA meeting is really about 19:39 The seven peptides, one by one 29:34 Six FDA safety concerns and cancer risk 32:44 Two questions for a legit provider MORE FROM GLP-1 HUB MORE FROM GLP-1 HUB 📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com 🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show. 🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com 📷 Follow on Instagram: @glp1hub 📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub *Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show. *The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.